openPR Logo
Press release

Small Interfering RNA (siRNA) Therapeutics Market Set to Reach US$ 39.19 Billion by 2030, Growing at a CAGR of 17.5%

Small Interfering RNA (siRNA) Therapeutics Market

Small Interfering RNA (siRNA) Therapeutics Market

๐’๐ฆ๐š๐ฅ๐ฅ ๐ˆ๐ง๐ญ๐ž๐ซ๐Ÿ๐ž๐ซ๐ข๐ง๐  ๐‘๐๐€ (๐’๐ˆ๐‘๐๐€) ๐“๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐†๐ซ๐จ๐ฐ๐ญ๐ก ๐จ๐ซ ๐ƒ๐ž๐ฆ๐š๐ง๐ ๐ˆ๐ง๐œ๐ซ๐ž๐š๐ฌ๐ž ๐จ๐ซ ๐ƒ๐ž๐œ๐ซ๐ž๐š๐ฌ๐ž ๐Ÿ๐จ๐ซ ๐ฐ๐ก๐š๐ญ ๐œ๐จ๐ง๐ญ๐š๐ข๐ง๐ฌ :

The Small Interfering RNA (siRNA) therapeutics market is experiencing significant growth, driven by the increasing prevalence of various diseases, including genetic disorders, cancer, and viral infections. The unique ability of siRNA to specifically target and silence disease-causing genes has made it a promising avenue in the field of molecular medicine. Advancements in delivery mechanisms, such as lipid nanoparticles and conjugation strategies, are enhancing the efficacy and stability of siRNA therapies, further fueling demand. Additionally, the rising investment in research and development by pharmaceutical companies and academic institutions is expected to lead to a steady increase in innovative siRNA therapeutics, contributing to market expansion. Overall, the market is positioned for robust growth as healthcare providers and patients seek more effective and targeted treatment options.

๐’๐ฆ๐š๐ฅ๐ฅ ๐ˆ๐ง๐ญ๐ž๐ซ๐Ÿ๐ž๐ซ๐ข๐ง๐  ๐‘๐๐€ (๐’๐ˆ๐‘๐๐€) ๐“๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‚๐€๐†๐‘ ๐„๐ฌ๐ญ๐ข๐ฆ๐š๐ญ๐ข๐จ๐ง:

The market for small interfering RNA (SIRNA) therapeutics is anticipated to grow at a compound annual growth rate (CAGR) of 17.5% to reach US$ 39.19 billion between 2024 and 2030.

๐„๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ž ๐š๐๐๐ข๐ญ๐ข๐จ๐ง๐š๐ฅ ๐๐ž๐ญ๐š๐ข๐ฅ๐ฌ ๐›๐ฒ ๐œ๐ฅ๐ข๐œ๐ค๐ข๐ง๐  ๐ญ๐ก๐ž ๐ฅ๐ข๐ง๐ค ๐ฉ๐ซ๐จ๐ฏ๐ข๐๐ž๐: https://www.maximizemarketresearch.com/request-sample/91788/

๐’๐ฆ๐š๐ฅ๐ฅ ๐ˆ๐ง๐ญ๐ž๐ซ๐Ÿ๐ž๐ซ๐ข๐ง๐  ๐‘๐๐€ (๐’๐ˆ๐‘๐๐€) ๐“๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง:

by Type

Liposome Based Systemic Therapy
Nanoparticle Based Systemic Therapy
Other

by Applications

Hospital, Research Institutions
Pharmaceutical and Biotechnology Companies
Academic Institutions
Other

Based on type, liposome-based systemic therapy is anticipated to have a leading market share since it is the most promising drug delivery technique for in vivo siRNA delivery. The first nano-drug delivery method to be effectively adapted for use in real-time clinical settings is liposomes. The most widely utilized liposome-based delivery systems in clinical settings are expanded by the second and third generations of liposomes' capacity to either boost liposome stabilities or recognize particular receptors. Each of these elements contributes to the growth of the segment.

๐’๐ฆ๐š๐ฅ๐ฅ ๐ˆ๐ง๐ญ๐ž๐ซ๐Ÿ๐ž๐ซ๐ข๐ง๐  ๐‘๐๐€ (๐’๐ˆ๐‘๐๐€) ๐“๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐Ž๐ฏ๐ž๐ซ๐ฏ๐ข๐ž๐ฐ

The Small Interfering RNA (siRNA) therapeutics market is rapidly evolving, driven by advancements in RNA interference technology and increasing investment in genetic therapies. siRNA molecules play a crucial role in gene silencing, allowing for targeted treatment of various diseases, particularly genetic disorders and cancers. The market has witnessed significant growth due to the rising demand for personalized medicine and the need for innovative therapeutic approaches that can specifically target disease-causing genes without affecting normal cellular functions. Additionally, a growing understanding of the underlying mechanisms of diseases and the ability to design siRNA molecules with high specificity and efficiency are propelling research and development efforts in this field. As regulatory frameworks become more supportive and clinical trials yield positive results, the siRNA therapeutics market is expected to expand significantly in the coming years, offering promising solutions for previously untreatable conditions.

๐„๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ž ๐š๐๐๐ข๐ญ๐ข๐จ๐ง๐š๐ฅ ๐๐ž๐ญ๐š๐ข๐ฅ๐ฌ ๐›๐ฒ ๐œ๐ฅ๐ข๐œ๐ค๐ข๐ง๐  ๐ญ๐ก๐ž ๐ฅ๐ข๐ง๐ค ๐ฉ๐ซ๐จ๐ฏ๐ข๐๐ž๐: https://www.maximizemarketresearch.com/request-sample/91788/

๐’๐ฆ๐š๐ฅ๐ฅ ๐ˆ๐ง๐ญ๐ž๐ซ๐Ÿ๐ž๐ซ๐ข๐ง๐  ๐‘๐๐€ (๐’๐ˆ๐‘๐๐€) ๐“๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐†๐ซ๐จ๐ฐ๐ญ๐ก ๐จ๐ซ ๐ƒ๐ž๐ฆ๐š๐ง๐ ๐ข๐ง ๐ฐ๐ก๐ข๐œ๐ก ๐ซ๐ž๐ ๐ข๐จ๐ง๐ฌ?

The research includes in-depth examinations of the Middle East, South America, Europe, Africa, and Asia-Pacific region. Understanding the intricate dynamics of the Small Interfering RNA (SIRNA) Therapeutics Market is one aspect of regional analysis. A framework of product imports and exports by nations and regions, as well as market sizes and growth rates for Small Interfering RNA (SIRNA) Therapeutics, are included in the report. An overview of the most current developments in the field from a number of different countries and areas is given in this paper.

๐’๐ฆ๐š๐ฅ๐ฅ ๐ˆ๐ง๐ญ๐ž๐ซ๐Ÿ๐ž๐ซ๐ข๐ง๐  ๐‘๐๐€ (๐’๐ˆ๐‘๐๐€) ๐“๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐’๐œ๐จ๐ฉ๐ž ๐š๐ง๐ ๐Œ๐ž๐ญ๐ก๐จ๐๐จ๐ฅ๐จ๐ ๐ฒ:

The scope of the Small Interfering RNA (siRNA) therapeutics market encompasses various aspects, including the development, production, and commercialization of siRNA-based therapies. This market includes applications in genetic disorders, cancer treatment, infectious diseases, and other conditions where gene silencing can offer therapeutic benefits. The methodology for analyzing this market involves a comprehensive approach, combining both qualitative and quantitative research techniques.

Market assessments include the evaluation of key players, their product pipelines, and ongoing clinical trials to gauge the competitive landscape. Data collection involves primary research through interviews with industry experts, researchers, and clinicians, along with secondary research from academic publications, market reports, and regulatory agency filings. The analysis also focuses on market trends, technological advancements, and regulatory challenges that could influence market growth. By integrating these methodologies, stakeholders can gain valuable insights into market dynamics, opportunities for innovation, and the potential for siRNA therapeutics to transform treatment paradigms across various disease areas.

๐…๐จ๐ซ ๐š ๐๐ž๐ž๐ฉ๐ž๐ซ ๐ฎ๐ง๐๐ž๐ซ๐ฌ๐ญ๐š๐ง๐๐ข๐ง๐ , ๐œ๐ฅ๐ข๐œ๐ค ๐จ๐ง ๐ญ๐ก๐ž ๐ฅ๐ข๐ง๐ค: https://www.maximizemarketresearch.com/request-sample/91788/

๐’๐ฆ๐š๐ฅ๐ฅ ๐ˆ๐ง๐ญ๐ž๐ซ๐Ÿ๐ž๐ซ๐ข๐ง๐  ๐‘๐๐€ (๐’๐ˆ๐‘๐๐€) ๐“๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐Š๐ž๐ฒ ๐๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ

1. GE Dharmacon
2. OPKO Health, Inc.
3. Alnylam Pharmaceuticals
4. Arrowhead Research Corp
5. Sanofi Genzyme
6. Genecon Biotechnologies Co., Ltd.
7. Arbutus Biopharma Corp
8. Silence Therapeutics AG
9. Sylentis S.A.
10. Olix Pharmaceuticals
11. GlaxoSmithKline
12. Isis Pharmaceuticals/ Ionis Pharmaceuticals
13. BenitecBiopharma Ltd.
14. Bio-Path Holdings Inc.
15. Calando Pharmaceuticals

๐“๐จ ๐š๐œ๐œ๐ž๐ฌ๐ฌ ๐ฆ๐จ๐ซ๐ž ๐œ๐จ๐ฆ๐ฉ๐ซ๐ž๐ก๐ž๐ง๐ฌ๐ข๐ฏ๐ž ๐ข๐ง๐Ÿ๐จ๐ซ๐ฆ๐š๐ญ๐ข๐จ๐ง, ๐œ๐ฅ๐ข๐œ๐ค ๐ก๐ž๐ซ๐ž: https://www.maximizemarketresearch.com/market-report/global-small-interfering-rna-sirna-therapeutics-market/91788/

๐Š๐ž๐ฒ ๐ช๐ฎ๐ž๐ฌ๐ญ๐ข๐จ๐ง๐ฌ ๐š๐ง๐ฌ๐ฐ๐ž๐ซ๐ž๐ ๐ข๐ง ๐ญ๐ก๐ž ๐’๐ฆ๐š๐ฅ๐ฅ ๐ˆ๐ง๐ญ๐ž๐ซ๐Ÿ๐ž๐ซ๐ข๐ง๐  ๐‘๐๐€ (๐’๐ˆ๐‘๐๐€) ๐“๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐š๐ซ๐ž:

โ€ข What is Small Interfering RNA (SIRNA) Therapeutics?
โ€ข What is the growth rate of the Small Interfering RNA (SIRNA) Therapeutics?
โ€ข Which are the factors expected to drive the Small Interfering RNA (SIRNA) Therapeutics Market growth?
โ€ข What are the different segments of the Small Interfering RNA (SIRNA) Therapeutics?
โ€ข What growth strategies are the players considering to increase their presence in Small Interfering RNA (SIRNA) Therapeutics?
โ€ข What are the upcoming industry applications and trends for the Small Interfering RNA (SIRNA) Therapeutics?
โ€ข What are the recent industry trends that can be implemented to generate additional revenue streams for the Small Interfering RNA (SIRNA) Therapeutics?
โ€ข What major challenges could the Small Interfering RNA (SIRNA) Therapeutics face in the future?
โ€ข What segments are covered in the Small Interfering RNA (SIRNA) Therapeutics?
โ€ข Who are the leading companies and what are their portfolios in Small Interfering RNA (SIRNA) Therapeutics?
โ€ข What segments are covered in the Small Interfering RNA (SIRNA) Therapeutics?
โ€ข Who are the key players in the Small Interfering RNA (SIRNA) Therapeutics Market?

๐‘๐ž๐ฅ๐š๐ญ๐ž๐ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ:

โ™ฆ Global Hardware Security Module Market https://www.maximizemarketresearch.com/market-report/global-hardware-security-module-market/55244/

โ™ฆ Global Industrial Automation and Control Systems Market https://www.maximizemarketresearch.com/market-report/global-industrial-automation-and-control-systems-market/106619/

โ™ฆ Global Oxygen Concentrators Market https://www.maximizemarketresearch.com/market-report/global-oxygen-concentrators-market/9845/

โ™ฆ Global Graphene Nanoplatelets Market https://www.maximizemarketresearch.com/market-report/global-graphene-nanoplatelets-market/103666/

โ™ฆ Global Industrial Display Market https://www.maximizemarketresearch.com/market-report/global-industrial-display-market/55710/

โ™ฆ Traumatic Brain Injuries Treatment Market https://www.maximizemarketresearch.com/market-report/traumatic-brain-injuries-treatment-market/14716/

โ™ฆ Physiotherapy Services Market https://www.maximizemarketresearch.com/market-report/global-physiotherapy-services-market/87625/

โ™ฆ Global Veterinary Reference Laboratory Market https://www.maximizemarketresearch.com/market-report/global-veterinary-reference-laboratory-market/84180/

โ™ฆ Global Sandwich Panel Market https://www.maximizemarketresearch.com/market-report/global-sandwich-panel-market/10807/

โ™ฆ Global Kids Wear Market https://www.maximizemarketresearch.com/market-report/global-kids-wear-market/108154/

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ ๐Œ๐š๐ฑ๐ข๐ฆ๐ข๐ณ๐ž ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก:

3rd Floor, Navale IT Park, Phase 2
Pune Banglore Highway, Narhe,
Pune, Maharashtra 411041, India
sales@maximizemarketresearch.com
+91 96071 95908, +91 9607365656

๐€๐›๐จ๐ฎ๐ญ ๐Œ๐š๐ฑ๐ข๐ฆ๐ข๐ณ๐ž ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก:

Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Small Interfering RNA (siRNA) Therapeutics Market Set to Reach US$ 39.19 Billion by 2030, Growing at a CAGR of 17.5% here

News-ID: 3712536 • Views: โ€ฆ

More Releases from MAXIMIZE MARKET RESEARCH PVT. LTD.

Bangladesh Ceramics Tiles Market to Surpass USD 2.1 Billion by 2030, Fueled by a Robust 13.71% CAGR
Bangladesh Ceramics Tiles Market to Surpass USD 2.1 Billion by 2030, Fueled by a โ€ฆ
Bangladesh Ceramics Tiles Market size was valued at USD 882.56 Million in 2023 and the total Bangladesh Ceramics Tiles Market revenue is expected to grow at a CAGR of 13.71 % from 2024 to 2030, reaching nearly USD 2169.38 Million. Bangladesh Ceramics Tiles Market Overview: The Bangladesh ceramics tiles market is a vital component of the country's construction and building materials industry, driven by rapid urbanization, infrastructure development, and rising disposable incomes.โ€ฆ
Furfural Market to Reach Nearly USD 1 Trillion by 2030, Propelled by a 6.8% CAGR
Furfural Market to Reach Nearly USD 1 Trillion by 2030, Propelled by a 6.8% CAGR
Furfural Market size was valued at USD 630.2Mn in 2023. The Furfural Market revenue is growing at a CAGR of 6.8 % from 2023 to 2029, reaching nearly USD 998.30 Bn by 2030. Furfural Market Overview: The furfural market is centered around an organic compound derived primarily from agricultural byproducts such as corn cobs, sugarcane bagasse, and rice husks through a process of acid hydrolysis. As one of the oldest renewable chemicals,โ€ฆ
Chemical Protective Clothing Market Valued at USD 1.57 Bn in 2024, Projected to Grow at a 5.59% CAGR Through 2032
Chemical Protective Clothing Market Valued at USD 1.57 Bn in 2024, Projected to โ€ฆ
Chemical Protective Clothing Market size was valued at USD 1.57 Billion in 2024 and the total Chemical Protective Clothing revenue is expected to grow at a CAGR of 5.59% from 2025 to 2032, reaching nearly USD 2.42 Billion. Chemical Protective Clothing Market Overview: The Chemical Protective Clothing (CPC) market comprises garments and accessories specifically designed to shield workers from exposure to hazardous chemicals, liquids, and particulate matter across a wide range ofโ€ฆ
Prefabricated Homes Market Valued at USD 18.58 Bn in 2024, Poised for 6.19% CAGR Growth to 2032
Prefabricated Homes Market Valued at USD 18.58 Bn in 2024, Poised for 6.19% CAGR โ€ฆ
Prefabricated Homes Market size was valued at USD 18.58 Billion in 2024 and the total Prefabricated Homes revenue is expected to grow at a CAGR of 6.19% from 2025 to 2032, reaching nearly USD 30.04 Billion. Prefabricated Homes Market Overview: The prefabricated homes market, also known as modular or off-site construction, involves the manufacturing of building components in a controlled factory environment before their assembly at the final location. This method revolutionizesโ€ฆ

All 5 Releases


More Releases for RNA

CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA โ€ฆ
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes. CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, andโ€ฆ
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca โ€ฆ
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034." According to the latest research by InsightAce Analytic,โ€ฆ
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca โ€ฆ
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032. This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through - โ€ข 70% efforts of Primary Research โ€ข 15% efforts of Secondary Research โ€ข 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limitedโ€ฆ
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin โ€ฆ
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate? โ€ข The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%. โ€ข Expected exponentialโ€ฆ
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe โ€ฆ
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032. The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers aโ€ฆ
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te โ€ฆ
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and mayโ€ฆ